Funding for this research was provided by:
Merck Sharp and Dohme
Text and Data Mining valid from 2019-04-16
Received: 21 February 2019
Accepted: 9 April 2019
First Online: 16 April 2019
Compliance with ethical standards
: Teresa Otón and Loreto Carmona’s institution (InMusc) has received consultancy honoraria from MSD. Outside this project, InMusc has received consultancy honoraria from Abbvie, Astellas, BMS, Eisay, Gebro Pharma, Leo Pharma, Lylly, Novartis, Pfizer, Roche, Sanofi-Aventis and UCB Pharma. Maria J. Arteaga and Luis Cea-Calvo are full time employees at Merck Sharp & Dohme of Spain. The remaining authors declare no conflict of interest.
: Ethics was approved by the Clinical Research Ethics Committee of Hospital Virgen de la Arrixaca. All subjects consented to participate in the study.